LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will host an invitation-only Investor Event at the Back Bay Events Center in Boston at 4:30 P.M. ET on Monday, September 8th, 2008. The presentations will focus on the scientific background for and the progress being made in the development of Cubist’s pipeline programs: multiple pre-IND anti-infective candidates and the Phase 2 compound, Ecallantide, being developed by Cubist for on-pump cardiothoracic surgery. The formal remarks, question and answer session, and slide presentation will be webcast live. The presentation will be accessible at www.cubist.com in the Investor Relations section and will be available via archive at www.cubist.com for 30 days following the event.
